The effects of ramelteon in a first-night model of transient insomnia
Authors:
- Gary ZammitGZGary Zammit
- Howard SchwartzHSHoward Schwartz
- Thomas RothTRThomas Roth
- Sherry Wang-WeigandSWSherry Wang-Weigand
- Steve SainatiSSSteve Sainati
- Jeff ZhangJZJeff Zhang
- 1 January 2009
- journal article
- research article
- Published by Elsevier in Sleep Medicine
- Vol. 10 (1) , 55-59
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomniaCurrent Medical Research and Opinion, 2007
- Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomniaSleep Medicine, 2006
- An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomniaSleep Medicine, 2006
- Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonistNeuropharmacology, 2005
- Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomniaCurrent Medical Research and Opinion, 2005
- An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adultsSleep Medicine, 2005
- Comparative efficacy of zolpidem and temazepam in transient insomniaHuman Psychopharmacology: Clinical and Experimental, 2001
- Molecular Dissection of Two Distinct Actions of Melatonin on the Suprachiasmatic Circadian ClockNeuron, 1997
- Zolpidem in the Treatment of Transient Insomnia: A Double-Blind, Randomized Comparison With PlaceboSLEEP, 1995
- THE FIRST NIGHT EFFECT: AN EEG STUDYOF SLEEPPsychophysiology, 1966